214 related articles for article (PubMed ID: 20797782)
1. Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents.
Ratzinger G; Agrawal P; Körner W; Lonkai J; Sanders HM; Terreno E; Wirth M; Strijkers GJ; Nicolay K; Gabor F
Biomaterials; 2010 Nov; 31(33):8716-23. PubMed ID: 20797782
[TBL] [Abstract][Full Text] [Related]
2. Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging.
Castonguay LA; Treasurywala AM; Caulfield TJ; Jaeger EP; Kellar KE
Bioconjug Chem; 1999; 10(6):958-64. PubMed ID: 10563764
[TBL] [Abstract][Full Text] [Related]
3. NMRD assessment of Gd-DTPA-bis(methoxyethylamide), (Gd-DTPA-BMEA), a nonionic MRI agent.
Adzamli K; Periasamy MP; Spiller M; Koenig SH
Invest Radiol; 1999 Jun; 34(6):410-4. PubMed ID: 10353033
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombus.
Zhang Y; Zhou J; Guo D; Ao M; Zheng Y; Wang Z
Int J Nanomedicine; 2013; 8():3745-56. PubMed ID: 24124363
[TBL] [Abstract][Full Text] [Related]
5. Nile Red Loaded PLGA Nanoparticles Surface Modified with Gd-DTPA for Potential Dual-Modal Imaging.
Li Q; Li C; Tong W
J Nanosci Nanotechnol; 2016 Jun; 16(6):5569-76. PubMed ID: 27427598
[TBL] [Abstract][Full Text] [Related]
6. Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics.
Shiraishi K; Kawano K; Maitani Y; Yokoyama M
J Control Release; 2010 Dec; 148(2):160-7. PubMed ID: 20804796
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
[TBL] [Abstract][Full Text] [Related]
8. Quantification and excretion kinetics of a magnetic resonance imaging contrast agent by capillary electrophoresis-mass spectrometry.
Künnemeyer J; Terborg L; Nowak S; Brauckmann C; Telgmann L; Albert A; Tokmak F; Krämer BK; Günsel A; Wiesmüller GA; Karst U
Electrophoresis; 2009 May; 30(10):1766-73. PubMed ID: 19441033
[TBL] [Abstract][Full Text] [Related]
9. Cyclen-based Gd
Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU
Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196
[TBL] [Abstract][Full Text] [Related]
10. Novel gadolinium(III) polyaminocarboxylate macrocyclic complexes as potential magnetic resonance imaging contrast agents.
Chan KW; Barra S; Botta M; Wong WT
J Inorg Biochem; 2004 May; 98(5):677-82. PubMed ID: 15134912
[TBL] [Abstract][Full Text] [Related]
11. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
12. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
13. Maximizing the relaxivity of Gd-complex by synergistic effect of HSA and carboxylfullerene.
Zhen M; Zheng J; Ye L; Li S; Jin C; Li K; Qiu D; Han H; Shu C; Yang Y; Wang C
ACS Appl Mater Interfaces; 2012 Jul; 4(7):3724-9. PubMed ID: 22704586
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
[TBL] [Abstract][Full Text] [Related]
16. The importance of nuclear magnetic relaxation dispersion (NMRD) profiles in MRI contrast media development.
Muller RN; Vander Elst L; Rinck PA; Vallet P; Maton F; Fischer H; Roch A; Van Haverbeke Y
Invest Radiol; 1988 Sep; 23 Suppl 1():S229-31. PubMed ID: 3198350
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.
Xiao Y; Xue R; You T; Li X; Pei F; Wang X; Lei H
Carbohydr Res; 2014 Aug; 395():9-14. PubMed ID: 24995911
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of gadoteric acid for delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) at the wrist and knee and comparison with Gd-DTPA.
Rehnitz C; Klaan B; Do T; Barié A; Kauczor HU; Weber MA
J Magn Reson Imaging; 2017 Nov; 46(5):1433-1440. PubMed ID: 28263424
[TBL] [Abstract][Full Text] [Related]
19. Magnetic poly(lactide-co-glycolide) and cellulose particles for MRI-based cell tracking.
Nkansah MK; Thakral D; Shapiro EM
Magn Reson Med; 2011 Jun; 65(6):1776-85. PubMed ID: 21404328
[TBL] [Abstract][Full Text] [Related]
20. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
